A Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses and Effect of Food on the Pharmacokinetics of DM1157 in Healthy Adults
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 25 May 2018
At a glance
- Drugs DM-1157 (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man; Pharmacodynamics
- 17 May 2018 Planned initiation date changed from 10 May 2018 to 1 Jun 2018.
- 19 Apr 2018 Planned initiation date changed from 19 Apr 2018 to 10 May 2018.
- 10 Apr 2018 New trial record